Different vaccine vectors delivering the same antigen elicit CD8 + T cell responses with distinct clonotype and epitope specificity

Journal of Immunology

Volumn 183, Issue 4, 2009, Pages 2425-2434

  Honda, Mitsuo ^a,b   Wang, Rui ^a   Kong, Wing Pui ^a   Kanekiyo, Masaru ^a   Akahata, Wataru ^a   Xu, Ling ^a   Matsuo, Kazuhiro ^b   Natarajan, Kannan ^a   Robinson, Howard ^c   Asher, Tedi E ^a   Price, David A ^a,d   Douek, Daniel C ^a   Margulies, David H ^a   Nabel, Gary J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VACCINE; GLYCOPROTEIN GP 120; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B); HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL MOTILITY; CELLULAR IMMUNITY; GENE VECTOR; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE; X RAY CRYSTALLOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; CELL CLONE; CELL CULTURE; CELL LINE; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; VIROLOGY;

AIDS VACCINES; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; H-2 ANTIGENS; HIV ENVELOPE PROTEIN GP120; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; PROTEIN BINDING;

EID: 70149088017     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900581     Document Type: Article

References (51)

1. Li, Y., S. A. Migueles, B. Welcher, K. Svehla, A. Phogat, M. K. Louder, X. Wu, G. M. Shaw, M. Connors, R. T. Wyatt, and J. R. Mascola. 2007. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat. Med. 13: 1032-1034.
2. Huang, C. C., S. N. Lam, P. Acharya, M. Tang, S. H. Xiang, S. S. Hussan, R. L. Stanfield, J. Robinson, J. Sodroski, I. A. Wilson, et al. 2007. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 317: 1930-1934.
3. Fischer, W., S. Perkins, J. Theiler, T. Bhattacharya, K. Yusim, R. Funkhouser, C. Kuiken, B. Haynes, N. L. Letvin, B. D. Walker, et al. 2007. Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat. Med. 13: 100-106.
4. Barouch, D. H., S. Santra, J. E. Schmitz, M. J. Kuroda, T. M. Fu, W. Wagner, M. Bilska, A. Craiu, X. X. Zheng, G. R. Krivulka, et al. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290: 486-492.
5. Shiver, J. W., T. M. Fu, L. Chen, D. R. Casimiro, M. E. Davies, R. K. Evans, Z. Q. Zhang, A. J. Simon, W. L. Trigona, S. A. Dubey, et al. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415: 331-335.
6. Graham, B. S., R. A. Koup, M. Roederer, R. T. Bailer, M. E. Enama, Z. Moodie, J. E. Martin, M. M. McCluskey, B. K. Chakrabarti, L. Lamoreaux, et al. 2006. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. J. Infect. Dis. 194: 1650-1660.
7. Harari, A., P. A. Bart, W. Stohr, G. Tapia, M. Garcia, E. Medjitna-Rais, S. Burnet, C. Cellerai, O. Erlwein, T. Barber, et al. 2008. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J. Exp. Med. 205: 63-77.
8. Mattapallil, J. J., D. C. Douek, A. Buckler-White, D. Montefiori, N. L. Letvin, G. J. Nabel, and M. Roederer. 2006. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J. Exp. Med. 203: 1533-1541.
9. Nabel, G. J. 2001. Challenges and opportunities for development of an AIDS vaccine. Nature 410: 1002-1007.
10. Letvin, N. L. 2007. Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity 27: 366-369. (Pubitemid 47418683)
11. + central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312: 1530-1533.
12. Reynolds, M. R., A. M. Weiler, K. L. Weisgrau, S. M. Piaskowski, J. R. Furlott, J. T. Weinfurter, M. Kaizu, T. Soma, E. J. Leon, C. MacNair, et al. 2008. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J. Exp. Med. 205: 2537-2550.
13. Chen, W., S. Khilko, J. Fecondo, D. H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180: 1471-1483. (Pubitemid 24289620)
14. Laugel, B., D. A. Price, and A. K. Sewell. 2006. On the path to TCR-directed therapeutics. Nat. Biotechnol. 24: 615-616.
15. Varela-Rohena, A., P. E. Molloy, S. M. Dunn, Y. Li, M. M. Suhoski, R. G. Carroll, A. Milicic, T. Mahon, D. H. Sutton, B. Laugel, et al. 2008. Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat. Med. 14: 1390-1395.
16. Letvin, N. L., Y. Huang, B. K. Chakrabarti, L. Xu, M. S. Seaman, K. Beaudry, B. Korioth-Schmitz, F. Yu, D. Rohne, K. L. Martin, et al. 2004. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. J. Virol. 78: 7490-7497.
17. Huang, C. C., M. Tang, M. Y. Zhang, S. Majeed, E. Montabana, R. L. Stanfield, D. S. Dimitrov, B. Korber, J. Sodroski, I. A. Wilson, et al. 2005. Structure of a V3-containing HIV-1 gp120 core. Science 310: 1025-1028.
18. Palker, T. J., M. E. Clark, A. J. Langlois, T. J. Matthews, K. J. Weinhold, R. R. Randall, D. P. Bolognesi, and B. F. Haynes. 1988. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85: 1932-1936.
19. Takahashi, H., R. Houghten, S. D. Putney, D. H. Margulies, B. Moss, R. N. Germain, and J. A. Berzofsky. 1989. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. J. Exp. Med. 170: 2023-2035.
20. Takahashi, H., S. Merli, S. D. Putney, R. Houghten, B. Moss, R. N. Germain, and J. A. Berzofsky. 1989. A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. Science 246: 118-121. (Pubitemid 19252089)
21. Bikoff, E. K., G. R. Otten, and E. J. Robertson. 1991. Defective assembly of class I major histocompatibility complex molecules in an embryonic cell line. Eur. J. Immunol. 21: 1997-2004.
22. Darrah, P. A., D. T. Patel, P. M. De Luca, R. W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850.
23. 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature 349: 74-77.
24. Betts, M. R., and R. A. Koup. 2004. Detection of T-cell degranulation: CD107a and b. Methods Cell Biol. 75: 497-512.
25. + T cell responses. J. Exp. Med. 204: 1405-1416.
26. Douek, D. C., M. R. Betts, J. M. Brenchley, B. J. Hill, D. R. Ambrozak, K. L. Ngai, N. J. Karandikar, J. P. Casazza, and R. A. Koup. 2002. A novel approach to the analysis of specificity, clonality, and frequency of HIV-specific T cell responses reveals a potential mechanism for control of viral escape. J. Immunol. 168: 3099-3104.
27. Li, H., K. Natarajan, E. L. Malchiodi, D. H. Margulies, and R. A. Mariuzza. 1998. Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. J. Mol. Biol. 283: 179-191.
28. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60: 2126-2132.
29. Wu, L., W. P. Kong, and G. J. Nabel. 2005. Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens. J. Virol. 79: 8024-8031.
30. Bergmann, C., S. A. Stohlmann, and M. McMillan. 1993. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein. Eur. J. Immunol. 23: 2777-2781.
31. Corr, M., L. F. Boyd, E. A. Padlan, and D. H. Margulies. 1993. H-2Dd exploits a four residue peptide binding motif. J. Exp. Med. 178: 1877-1892. (Pubitemid 2021437)
32. Tormo, J., K. Natarajan, D. H. Margulies, and R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402: 623-631. (Pubitemid 129516325)
33. Wu, L., Z. Y. Yang, L. Xu, B. Welcher, S. Winfrey, Y. Shao, J. R. Mascola, and G. J. Nabel. 2006. Cross-clade recognition and neutralization by the V3 region from clade C human immunodeficiency virus-1 envelope. Vaccine 24: 4995-5002.
34. Welsh, R. M. 2006. Private specificities of heterologous immunity. Curr. Opin. Immunol. 18: 331-337.
35. Kedl, R. M., J. W. Kappler, and P. Marrack. 2003. Epitope dominance, competition and T cell affinity maturation. Curr. Opin. Immunol. 15: 120-127.
36. Hansen, S. G., C. Vieville, N. Whizin, L. Coyne-Johnson, D. C. Siess, D. D. Drummond, A. W. Legasse, M. K. Axthelm, K. Oswald, C. M. Trubey, et al. 2009. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15: 293-299.
37. Chen, W., L. C. Anton, J. R. Bennink, and J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12: 83-93. (Pubitemid 30069217)
38. + T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen. J. Exp. Med. 191: 1687-1698.
39. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
40. Sarkar, S., V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625-640.
41. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
42. Hulsmeyer, M., M. T. Fiorillo, F. Bettosini, R. Sorrentino, W. Saenger, A. Ziegler, and B. Uchanska-Ziegler. 2004. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J. Exp. Med. 199: 271-281.
43. Ruckert, C., M. T. Fiorillo, B. Loll, R. Moretti, J. Biesiadka, W. Saenger, A. Ziegler, R. Sorrentino, and B. Uchanska-Ziegler. 2006. Conformational dimorphism of self-peptides and molecular mimicry in a disease-associated HLAB27 subtype. J. Biol. Chem. 281: 2306-2316.
44. Lovitch, S. B., T. J. Esparza, G. Schweitzer, J. Herzog, and E. R. Unanue. 2007. Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. J. Immunol. 178: 122-133.
45. Yewdell, J. W., J. R. Bennink, and Y. Hosaka. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239: 637-640.
46. Cresswell, P., A. L. Ackerman, A. Giodini, D. R. Peaper, and P. A. Wearsch. 2005. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207: 145-157.
47. Dobano, C., W. O. Rogers, K. Gowda, and D. L. Doolan. 2007. Targeting antigen to MHC class I and class II antigen presentation pathways for malaria DNA vaccines. Immunol. Lett. 111: 92-102.
48. Kawashima, T., Y. Norose, Y. Watanabe, Y. Enomoto, H. Narazaki, E. Watari, S. Tanaka, H. Takahashi, I. Yano, M. B. Brenner, and M. Sugita. 2003. Cutting edge: major CD8 T cell response to live bacillus Calmette-Guerin is mediated by CD1 molecules. J. Immunol. 170: 5345-5348.
49. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11: 403-450. (Pubitemid 23115014)
50. Sekaly, R. P. 2008. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J. Exp. Med. 205: 7-12.
51. + T cell efficacy in vaccination and disease. Nat. Med. 14: 623-628.